Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05141045 · ClinicalTrials.gov registry record · NA
The Effect of Fish Oil Supplementation on Vocal Performance
A NA study, sponsored by Baylor University.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT05141045: Completed NA study, sponsored by Baylor University.
NCT05141045 is a NA study that has completed, run by Baylor University. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05141045, a NA study, has completed, sponsored by Baylor University.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this study was to determine if use of omega-3 PUFA supplement in combination with a singer's training regimen enhances training adaptations and body composition.
Primary Outcome
survey designed to aid in subject self-assessment
Interventions
- DIETARY_SUPPLEMENT placebo
- DIETARY_SUPPLEMENT omega-3 PUFA supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-02-08 |
| Est. Completion | 2021-05-13 |
| Phase | NA |
What the finished NCT05141045 record still lists
NCT05141045 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT05141045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05141045 about?
NCT05141045 is a clinical study titled "The Effect of Fish Oil Supplementation on Vocal Performance". The purpose of this study was to determine if use of omega-3 PUFA supplement in combination with a singer's training regimen enhances training adaptations and body composition.
What is the current status of trial NCT05141045?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2021-02-08. Estimated completion is 2021-05-13.
What interventions are being tested in trial NCT05141045?
The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), omega-3 PUFA supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05141045?
This trial is sponsored by Baylor University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05141045's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI